PCTTWHIGH SIGNALFINANCIAL10-K

PureCycle Technologies experienced a severe 75% decline in stockholders' equity while burning through substantial cash as the polypropylene recycling company continues struggling with operational challenges at its Ironton facility.

The dramatic erosion of shareholder equity from $180M to $46M signals serious financial distress for this early-stage recycling technology company. The removal of language about the Ironton facility's commissioning activities and capacity expectations suggests ongoing operational difficulties in scaling their polypropylene dissolution process to commercial viability.

Comparing 2026-02-26 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

PureCycle's financial position deteriorated significantly with stockholders' equity collapsing by three-quarters despite total assets growing 16% to $923M. The company reduced its net losses meaningfully from the prior year and cut capital expenditures by 27%, but operating losses actually widened to $181M. This pattern suggests a company still burning cash heavily while struggling to achieve the operational milestones needed to generate meaningful revenue from its recycling technology.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
-74.6%
$180.4M$45.9M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Net Income
P&L
+36.9%
-$289.1M-$182.6M

Net income grew 36.9% — bottom-line growth signals improving overall business health.

Capital Expenditure
Cash Flow
-26.5%
$55.6M$40.8M

Capex reduced 26.5% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Operating Income
P&L
-24.8%
-$145.4M-$181.4M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Inventory
Balance Sheet
+15.9%
$8.1M$9.4M

Inventory built 15.9% — monitor whether demand supports this build or if write-downs may follow.

Total Assets
Balance Sheet
+15.6%
$798.4M$922.7M

Asset base grew 15.6% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-27
ADDED
As of February 23, 2026, there were 180,599,416 shares of the registrant's common stock outstanding.
When used in this report, the terms we, us, our, PCT and the Company mean PureCycle Technologies, Inc.
Overview When used in this report, the terms we, us, our, PCT and the Company mean PureCycle Technologies, Inc.
We are a Florida-based corporation focused on commercializing a patented dissolution recycling technology for polypropylene that physically separates the polymer from other plastics, colors, odors and impurities (the Technology ).
The Technology was originally developed by P G and is designed to restore recycled polypropylene waste into like-new resin, called PureFive resin.
+7 more — sign up free →
REMOVED
As of February 24, 2025, there wer e 179,336,275 shares of the registrant's common stock outstanding.
("PCT" or the "Company") is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology ), originally developed by The Procter Gamble Company ( P G ), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin.
PureFive resin represents the family of recycled resin products we produce, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene.
In April 2023, we certified as mechanically complete the Ironton Facility, which we expect to have capacity of approximately 107 million pounds per year when fully operational.
Commissioning activities are ongoing, but the plant is not yet operating at the expected full capacity.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →